Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2

NCT03296826 is registered in ClinicalTrials.gov with Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan as lead sponsor.

NCT NCT03296826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03296826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2
Lead sponsor
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Phase
Observational
Overall status
Recruiting
Start date
November 8, 2017
Completion date
March 31, 2032
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brca1 and/or brca2 variant carriers, fallopian tube carcinoma, ovarian carcinoma, peritoneal carcinoma